Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study

Ida Laake, Gro Tunheim, Anna Hayman Robertson, Olav Hungnes, Kristian Waalen, Siri E Håberg, Siri Mjaaland, Lill Trogstad, Ida Laake, Gro Tunheim, Anna Hayman Robertson, Olav Hungnes, Kristian Waalen, Siri E Håberg, Siri Mjaaland, Lill Trogstad

Abstract

Background: The effects of maternal influenza infection on the fetus remain unclear. We studied mild influenza and influenza antibodies in relation to birth weight and risks of pre-eclampsia, preterm birth (PTB), and small for gestational age (SGA) birth among the unvaccinated participants in the Norwegian Influenza Pregnancy Cohort.

Methods: Pregnant women attending a routine ultrasound were recruited from four hospitals in Norway shortly after the 2009 A(H1N1) pandemic. The present study was restricted to unvaccinated participants who were pregnant during the pandemic. Information on the participants was obtained through questionnaires and linkage with national registries. Maternal blood samples were collected at delivery. Women with laboratory-confirmed A(H1N1)pdm09 influenza, a clinical diagnosis of influenza, or self-reported influenza during the pandemic were classified as having had influenza. A(H1N1)pdm09-specific antibodies in serum were detected with the hemagglutination-inhibition assay. Detection of antibodies was considered an indicator of infection during the pandemic in the unvaccinated participants. Odds ratios were estimated with logistic regression. Quantile regression was used to estimate differences in the distribution of birth weight.

Results: Among the 1258 women included in this study, there were 37 cases of pre-eclampsia, 41 births were PTB, and 103 births were SGA. 226 women (18.0%) had influenza during the pandemic. The majority of cases did not receive medical care, and only a small proportion (1.3%) of the cases were hospitalized. Thus, the cases consisted primarily of women with mild illness. No significant associations between influenza and risk of pre-eclampsia, PTB, or SGA birth were observed. Detection of A(H1N1)pdm09-specific antibodies was associated with a lower 10th percentile of birth weight, β = - 159 g (95% CI - 309, - 9).

Conclusions: Mild influenza illness during pregnancy was not associated with increased risk of pre-eclampsia, PTB or SGA birth. However, influenza infection during pregnancy may reduce the birth weight of the smallest children.

Keywords: A(H1N1)pdm09; Antibodies; Birth outcomes; Influenza; Pandemic; Pregnancy.

Conflict of interest statement

Ethics approval and consent to participate

The study was approved by the Regional Committee for Medical and Health Research Ethics, Southeast Norway on December 22, 2009 (reference number 2009/2165). Written informed consent was obtained from all participants.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flow chart of the participants

References

    1. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8:e1001053. doi: 10.1371/journal.pmed.1001053.
    1. Mertz D, Geraci J, Winkup J, Gessner BD, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 2017;35:521–528. doi: 10.1016/j.vaccine.2016.12.012.
    1. Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J. 2008;12:223–242. doi: 10.1007/s10995-007-0224-1.
    1. Acs N, Banhidy F, Puho E, Czeizel AE. Pregnancy complications and delivery outcomes of pregnant women with influenza. J Matern Fetal Neonatal Med. 2006;19:135–140. doi: 10.1080/14767050500381180.
    1. Rogers VL, Sheffield JS, Roberts SW, McIntire DD, Luby JP, Trevino S, et al. Presentation of seasonal influenza a in pregnancy: 2003-2004 influenza season. Obstet Gynecol. 2010;115:924–929. doi: 10.1097/AOG.0b013e3181da0c5e.
    1. Mendez-Figueroa H, Raker C, Anderson BL. Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol. 2011;204:S58–S63. doi: 10.1016/j.ajog.2011.02.058.
    1. Nieto-Pascual L, Arjona-Berral JE, Marin-Martin EM, Munoz-Gomariz E, Ilich I, Castelo-Branco C. Early prophylactic treatment in pregnant women during the 2009-2010 H1N1 pandemic: obstetric and neonatal outcomes. J Obstet Gynaecol. 2013;33:128–134. doi: 10.3109/01443615.2012.740526.
    1. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;362:27–35. doi: 10.1056/NEJMoa0910444.
    1. The ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 a/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;340:c1279.
    1. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza a(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517–1525. doi: 10.1001/jama.2010.479.
    1. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol. 2006;107:1315–1322. doi: 10.1097/.
    1. McNeil SA, Dodds LA, Fell DB, Allen VM, Halperin BA, Steinhoff MC, et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol. 2011;204:S54–S57. doi: 10.1016/j.ajog.2011.04.031.
    1. Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011;342:d3214. doi: 10.1136/bmj.d3214.
    1. Hansen C, Desai S, Bredfeldt C, Cheetham C, Gallagher M, Li DK, et al. A large, population-based study of 2009 pandemic influenza a virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis. 2012;206:1260–1268. doi: 10.1093/infdis/jis488.
    1. Håberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013;368:333–340. doi: 10.1056/NEJMoa1207210.
    1. Naresh A, Fisher BM, Hoppe KK, Catov J, Xu J, Hart J, et al. A multicenter cohort study of pregnancy outcomes among women with laboratory-confirmed H1N1 influenza. J Perinatol. 2013;33:939–943. doi: 10.1038/jp.2013.110.
    1. Doyle TJ, Goodin K, Hamilton JJ. Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza a(H1N1) illness in Florida, 2009-2010: a population-based cohort study. PLoS One. 2013;8:e79040. doi: 10.1371/journal.pone.0079040.
    1. Fell DB, Platt RW, Basso O, Wilson K, Kaufman JS, Buckeridge DL, et al. The relationship between 2009 pandemic H1N1 influenza during pregnancy and preterm birth: a population-based cohort study. Epidemiology. 2018;29:107–116. doi: 10.1097/EDE.0000000000000753.
    1. Fell DB, Savitz DA, Kramer MS, Gessner BD, Katz MA, Knight M, et al. Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG. 2017;124:48–59. doi: 10.1111/1471-0528.14143.
    1. Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the flu watch cohort study. Lancet Respir Med. 2014;2:445–454. doi: 10.1016/S2213-2600(14)70034-7.
    1. Guzman Herrador BR, Aavitsland P, Feiring B, Riise Bergsaker MA, Borgen K. Usefulness of health registries when estimating vaccine effectiveness during the influenza a(H1N1)pdm09 pandemic in Norway. BMC Infect Dis. 2012;12:63. doi: 10.1186/1471-2334-12-63.
    1. Magnus P, Irgens LM, Haug K, Nystad W, Skjærven R, Stoltenberg C, et al. Cohort profile: the Norwegian mother and child cohort study (MoBa) Int J Epidemiol. 2006;35:1146–1150. doi: 10.1093/ije/dyl170.
    1. Skjærven R, Gjessing HK, Bakketeig LS. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand. 2000;79:440–449. doi: 10.1080/j.1600-0412.2000.079006440.x.
    1. Waalen K, Kilander A, Dudman SG, Ramos-Ocao R, Hungnes O. Age-dependent prevalence of antibodies cross-reactive to the influenza a(H3N2) variant virus in sera collected in Norway in 2011. Euro Surveill. 2012;17(19):20170.
    1. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, Hungnes O. High prevalence of antibodies to the 2009 pandemic influenza a(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill. 2010;15(31):19633.
    1. Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B. The Norwegian immunisation register—SYSVAK. Euro Surveill. 2012;17(16):20147.
    1. Koenker R, Hallock KF. Quantile regression. J Econ Perspect. 2001;15:143–156. doi: 10.1257/jep.15.4.143.
    1. Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of a(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respir Viruses. 2013;7:872–886. doi: 10.1111/irv.12074.
    1. The Norwegian Institute of Public Health. Influensaovervåking 2009–10, uke 52 og 53 [Influenza surveillance 2009–10, week 52 and 53]. . Accessed 30 Nov 2017. (In Norwegian).
    1. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972;70:767–777. doi: 10.1017/S0022172400022610.
    1. Zhao X, Siegel K, Chen MI, Cook AR. Rethinking thresholds for serological evidence of influenza virus infection. Influenza Other Respir Viruses. 2017;11:202–210. doi: 10.1111/irv.12452.
    1. Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, Aranio D, et al. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol. 2011;49:2210–2215. doi: 10.1128/JCM.00229-11.
    1. Hsu JP, Zhao X, Chen MI, Cook AR, Lee V, Lim WY, et al. Rate of decline of antibody titers to pandemic influenza a (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore. BMC Infect Dis. 2014;14:414. doi: 10.1186/1471-2334-14-414.
    1. Zeitlin J, Szamotulska K, Drewniak N, Mohangoo AD, Chalmers J, Sakkeus L, et al. Preterm birth time trends in Europe: a study of 19 countries. BJOG. 2013;120:1356–1365. doi: 10.1111/1471-0528.12281.
    1. The Norwegian Institute of Public Health. Medical Birth Registry of Norway statistics bank. . Accessed 16 Aug 2018.
    1. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol. 2009;23:597–608. doi: 10.1111/j.1365-3016.2009.01062.x.
    1. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061. doi: 10.1136/bmj.f5061.
    1. Wilson MG, Stein AM. Teratogenic effects of asian influenza. An extended study. JAMA. 1969;210:336–337. doi: 10.1001/jama.1969.03160280076019.
    1. Korones SB, Todaro J, Roane JA, Sever JL. Maternal virus infection after the first trimester of pregnancy and status of offspring to 4 years of age in a predominantly negro population. J Pediatr. 1970;77:245–251. doi: 10.1016/S0022-3476(70)80331-6.
    1. Griffiths PD, Ronalds CJ, Heath RB. A prospective study of influenza infections during pregnancy. J Epidemiol Community Health. 1980;34:124–128. doi: 10.1136/jech.34.2.124.
    1. Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG. 2000;107:1282–1289. doi: 10.1111/j.1471-0528.2000.tb11621.x.
    1. Steinhoff MC, Omer SB, Roy E, El Arifeen S, Raqib R, Dodd C, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ. 2012;184:645–653. doi: 10.1503/cmaj.110754.
    1. Steinhoff MC, Katz J, Englund JA, Khatry SK, Shrestha L, Kuypers J, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis. 2017;17:981–989. doi: 10.1016/S1473-3099(17)30252-9.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit